- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,534GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,534GBP
- Report
- April 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,534GBP
- Report
- August 2025
- 180 Pages
Global
From €4006EUR$4,500USD£3,542GBP
- Report
- June 2025
- 185 Pages
Global
From €4006EUR$4,500USD£3,542GBP
- Report
- May 2025
- 180 Pages
Global
From €4006EUR$4,500USD£3,542GBP
- Report
- February 2025
- 182 Pages
Global
From €4006EUR$4,500USD£3,542GBP
- Report
- February 2025
- 182 Pages
Global
From €4006EUR$4,500USD£3,542GBP
- Report
- November 2025
- 190 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- November 2025
- 193 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- November 2025
- 193 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- November 2025
- 194 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- October 2025
- 191 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- August 2025
- 196 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- November 2025
- 176 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- November 2025
- 273 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- November 2025
- 245 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- September 2025
- 250 Pages
Global
From €3997EUR$4,490USD£3,534GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,534GBP
- Report
- February 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,534GBP

The Human Albumin market is a subset of the biotechnology industry that focuses on the production and sale of human albumin, a protein found in human blood plasma. Human albumin is used in a variety of medical treatments, including the treatment of shock, burns, and other trauma-related conditions. It is also used in the production of a variety of pharmaceuticals, including vaccines and drugs.
The Human Albumin market is highly regulated, with strict standards for quality and safety. Companies in the market must adhere to stringent regulations and guidelines set by the US Food and Drug Administration (FDA) and other regulatory bodies.
The Human Albumin market is highly competitive, with a number of companies competing for market share. Companies in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more